Topic

Sickle Cell Disease

Speedway Scene reporting, analysis and commentary on Sickle Cell Disease, pulled together from across our coverage.

1 article Last updated: 6 Jul 2026 1 section

Connected sections Health

Connected topics Casgevy Vertex Pharmaceuticals CRISPR gene therapy Federal Reserve Donald Trump Iran

Lead story

Vertex Pharmaceuticals headquarters in Boston. Photo: ajay_suresh, CC BY 4.0, via Wikimedia Commons

Health

Vertex Gene Therapy Reaches Toddlers as FDA Lowers Casgevy Age Floor to Two

Federal regulators lowered the age floor for Vertex's one-time gene-editing therapy from 12 to 2, making Casgevy the first genetic medicine indicated for young children with two inherited blood disorders.

6 Jul 2026 ·6 min read

Read on

Keep following this story

Everything Speedway Scene has published on Sickle Cell Disease, gathered in one place: the reporting, the analysis and the commentary that track the subject.

Connected topics

Casgevy Vertex Pharmaceuticals CRISPR gene therapy Federal Reserve Donald Trump Iran Array Ukraine Kevin Warsh CDC

Connected sections